Phase 2 Breast Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women between 18 and 75 years old who are postmenopausal (either through surgical removal of the ovaries, being aged 60 or over, or having had no periods for 12 or more consecutive months with blood test results confirming menopause), OR premenopausal or perimenopausal women who are willing to receive a hormone-suppressing injection treatment during the study
- Women who have been diagnosed with breast cancer confirmed by a tissue sample, where the cancer tests positive for estrogen receptor (ER above 10%), progesterone receptor (PR above 1%), and HER2 protein (confirmed by laboratory testing methods)
- Women who have been diagnosed with stage II or stage III breast cancer (based on a standard cancer staging system) and are being treated for breast cancer for the first time
- People whose general health and ability to carry out daily activities meets a minimum score on a standard medical scale (confirm with trial site)
- People whose blood, liver, kidney, and heart function test results meet specific minimum levels set by the trial (confirm with trial site for exact values)
- People who are able to undergo a tissue biopsy
- People who are willing to participate, able to sign a consent form, and willing to attend follow-up appointments
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have already received any cancer treatment, such as chemotherapy, radiation therapy, targeted therapy, or hormone therapy
- People who are currently receiving other cancer treatments at the same time
- People who have cancer in both breasts, inflammatory breast cancer, or a form of breast cancer with no detectable breast lump
- People who have stage IV (advanced/spread) breast cancer
- People whose breast cancer has not been confirmed by a tissue sample
- People who have had another type of cancer in the past 5 years (except for cervical cancer in situ that has been fully treated)
- People who have serious problems with the functioning of the heart, liver, kidneys, or other major organs
- People who have conditions that may affect the ability to take or absorb medication, such as difficulty swallowing, ongoing diarrhea, or a bowel blockage
- People who have taken part in another clinical drug trial within the past 4 weeks
- People with a known allergy to any of the study drugs, or a history of immune system disorders (including HIV, hepatitis C, active hepatitis B, other immune deficiency conditions, or a history of organ transplant)
- People with a history of significant heart conditions, including heart rhythm problems requiring medication, heart attack, heart failure, or other heart disease considered unsuitable by the trial doctor
- Women who are pregnant or breastfeeding, women of childbearing age who test positive for pregnancy at the start of the trial, or women of childbearing age who are unwilling to use effective contraception throughout the study
- People with other serious ongoing health conditions — such as severe high blood pressure, severe diabetes, or active infections that cannot be controlled with medication — that could affect health or study participation
- People with a diagnosed neurological or psychiatric condition, such as epilepsy or dementia
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Cai-Gang Liu, PHD, Shengjing Hospital
Phone: +8618940256668
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Total pathological complete response (tpCR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.